Affiliation: Imperial College
- Imatinib mesylate (Gleevec/Glivec) a molecular-targeted therapy for chronic myeloid leukaemia and other malignanciesE Nadal
Haematology Department, Hammersmith Hospital, Imperial College, London, UK
Int J Clin Pract 58:511-6. 2004..Imatinib is an example of how a better understanding of the pathogenetic mechanisms of a neoplastic disease can lead to the development of a molecular-targeted therapy...
- Lymphoid transformation in a CML patient in complete cytogenetic remission following treatment with imatinibS Avery
Department of Haematology, Imperial College London at Hammersmith Hospital, Du Cane Road, London W12 0NN, UK
Leuk Res 28:S75-7. 2004..The case highlights the need for molecular monitoring of responders and the need to develop strategies for reducing to a minimum or totally eradicating leukemia cells...